Trial
NCT02023905
Everolimus With and Without Temozolomide in Adult Low Grade Glioma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, San Francisco
Collaborators
Novartis
Condition
Low Grade Glioma
Intervention
Everolimus
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-12-29